BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30755260)

  • 1. CXCL17-derived CD11b
    Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL
    Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of CD11b(+)Ly6G (+)Ly6C (int) cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions.
    Spallanzani RG; Dalotto-Moreno T; Raffo Iraolagoitia XL; Ziblat A; Domaica CI; Avila DE; Rossi LE; Fuertes MB; Battistone MA; Rabinovich GA; Salatino M; Zwirner NW
    Cancer Immunol Immunother; 2013 Dec; 62(12):1781-95. PubMed ID: 24114144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of p38 kinase impedes the mobilization of protumorigenic myeloid populations to impact breast cancer metastasis.
    Zonneville J; Colligan S; Grant S; Miller A; Wallace P; Abrams SI; Bakin AV
    Int J Cancer; 2020 Oct; 147(8):2279-2292. PubMed ID: 32452014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group 2 innate lymphoid cells promote TNBC lung metastasis via the IL-13-MDSC axis in a murine tumor model.
    Zhao N; Zhu W; Wang J; Liu W; Kang L; Yu R; Liu B
    Int Immunopharmacol; 2021 Oct; 99():107924. PubMed ID: 34217145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic targeting with DABIL-4 depletes myeloid suppressor cells in 4T1 triple-negative breast cancer model.
    Parveen S; Siddharth S; Cheung LS; Kumar A; Shen J; Murphy JR; Sharma D; Bishai WR
    Mol Oncol; 2021 May; 15(5):1330-1344. PubMed ID: 33682324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LAL deficiency induced myeloid-derived suppressor cells as targets and biomarkers for lung cancer.
    Zhao T; Liu S; Hanna NH; Jalal S; Ding X; Wan J; Yan C; Du H
    J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36914206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-educated Gr1+CD11b+ cells drive breast cancer metastasis via OSM/IL-6/JAK-induced cancer cell plasticity.
    Peyvandi S; Bulliard M; Yilmaz A; Kauzlaric A; Marcone R; Haerri L; Coquoz O; Huang YT; Duffey N; Gafner L; Lorusso G; Fournier N; Lan Q; Rüegg C
    J Clin Invest; 2024 Jan; 134(6):. PubMed ID: 38236642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome.
    Choreño-Parra JA; Jiménez-Álvarez LA; Ramírez-Martínez G; Sandoval-Vega M; Salinas-Lara C; Sánchez-Garibay C; Luna-Rivero C; Hernández-Montiel EM; Fernández-López LA; Cabrera-Cornejo MF; Choreño-Parra EM; Cruz-Lagunas A; Domínguez A; Márquez-García E; Cabello-Gutiérrez C; Bolaños-Morales FV; Mena-Hernández L; Delgado-Zaldivar D; Rebolledo-García D; Guadarrama-Ortiz P; Regino-Zamarripa NE; Mendoza-Milla C; García-Latorre EA; Rodiguez-Reyna TS; Cervántes-Rosete D; Hernández-Cárdenas CM; Khader SA; Zlotnik A; Zúñiga J
    Front Immunol; 2021; 12():633297. PubMed ID: 33717172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulating the expression of IFN regulatory factor 8 alters the protumorigenic behavior of CD11b+Gr-1+ myeloid cells.
    Stewart TJ; Liewehr DJ; Steinberg SM; Greeneltch KM; Abrams SI
    J Immunol; 2009 Jul; 183(1):117-28. PubMed ID: 19542426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL17 binds efficaciously to glycosaminoglycans with the potential to modulate chemokine signaling.
    Giblin SP; Ranawana S; Hassibi S; Birchenough HL; Mincham KT; Snelgrove RJ; Tsuchiya T; Kanegasaki S; Dyer D; Pease JE
    Front Immunol; 2023; 14():1254697. PubMed ID: 37942327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diet-induced obesity accelerates oral carcinogenesis by recruitment and functional enhancement of myeloid-derived suppressor cells.
    Peng J; Hu Q; Chen X; Wang C; Zhang J; Ren X; Wang Y; Tao X; Li H; Song M; Cheng B; Wu T; Xia J
    Cell Death Dis; 2021 Oct; 12(10):946. PubMed ID: 34650054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Targeting of Vasculature in the Premetastatic and Metastatic Niches Reduces Lung Metastasis.
    Ghouse SM; Vadrevu SK; Manne S; Reese B; Patel J; Patel B; Silwal A; Lodhi N; Paterson Y; Srivastava SK; Karbowniczek M; Markiewski MM
    J Immunol; 2020 Feb; 204(4):990-1000. PubMed ID: 31900334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric detection of CD11b
    Kitamura H
    Methods Cell Biol; 2024; 184():17-32. PubMed ID: 38555156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gr1(int)CD11b+ myeloid-derived suppressor cells in Mycobacterium tuberculosis infection.
    Obregón-Henao A; Henao-Tamayo M; Orme IM; Ordway DJ
    PLoS One; 2013; 8(11):e80669. PubMed ID: 24224058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer.
    Wang D; Sun H; Wei J; Cen B; DuBois RN
    Cancer Res; 2017 Jul; 77(13):3655-3665. PubMed ID: 28455419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Detection of Myeloid-Derived Suppressor Cells in the Lung Pre-Metastatic Niche by Shortwave Infrared Nanoprobes.
    Siebert JN; Shah JV; Tan MC; Riman RE; Pierce MC; Lattime EC; Ganapathy V; Moghe PV
    Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation.
    Wang Y; Ding Y; Guo N; Wang S
    Front Immunol; 2019; 10():172. PubMed ID: 30792719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recruitment of a myeloid cell subset (CD11b/Gr1 mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis.
    Zhao L; Lim SY; Gordon-Weeks AN; Tapmeier TT; Im JH; Cao Y; Beech J; Allen D; Smart S; Muschel RJ
    Hepatology; 2013 Feb; 57(2):829-39. PubMed ID: 23081697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans.
    White CW; Platt S; Kilpatrick LE; Dale N; Abhayawardana RS; Dekkers S; Kindon ND; Kellam B; Stocks MJ; Pfleger KDG; Hill SJ
    Sci Signal; 2024 Mar; 17(828):eabl3758. PubMed ID: 38502733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial YAP/TEAD1-CXCL17 signaling recruits myeloid-derived suppressor cells against liver ischemia-reperfusion injury.
    Zhang S; Sun Z; Chen Z; Bi Y; Wei S; Mao Z; Jin J; Ding Y; Wang W
    Hepatology; 2024 Feb; ():. PubMed ID: 38407233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.